|
| 2009～2011年武汉地区抗肿瘤分子靶向治疗药物应用分析 |
| Utilization of Antineoplastic for Molecular Target Therapy in Hospitals of Wuhan During 2009-2011 |
| |
| DOI： |
| 中文关键词: 抗肿瘤药 分子靶向治疗 销售金额 用药频度 日均费用 药物利用 |
| 英文关键词:Antineoplastic Molecular target therapy Consumption sum DDDs DDC Drug utilization |
| 基金项目: |
|
| 摘要点击次数: 2681 |
| 全文下载次数: 3804 |
| 中文摘要: |
| 摘 要 目的：了解武汉地区医院抗肿瘤分子靶向治疗药物的使用情况与特点。方法：对武汉地区32家医院2009~2011年抗肿瘤分子靶向治疗药物的应用品种、销售金额、用药频度（DDDs）及日均费用（DDC）等进行回顾性统计和分析。结果：武汉地区抗肿瘤分子靶向治疗药物销售金额与DDDs呈逐年增长趋势，DDC相对稳定。结论：2009~2011年武汉地区抗肿瘤分子靶向治疗药物应用状况和发展趋势较为合理。 |
| 英文摘要: |
| ABSTRACT Objective:To investigate the utilization and characteristics of antineoplastic for molecular target therapy in hospitals of Wuhan.Methods:The utilization data of antineoplastic for molecular target therapy were statistically analyzed in 32 hospitals of Wuhan during 2009-2011 in terms of category,consumption sum,DDDs,and DDC. Results:The consumption sum and DDDs of antineoplastic for molecular target therapy were increasing year by year, and the DDC leveled off. Conclusion:The utilization of antineoplastic for molecular target therapy is reasonable. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
